A county public-health clinic Product Owner is praised because Time-to-Market dropped after releasing a walk-in immunization check-in that still fails the Definition of Done—dose-lot verification is skipped. What should the Product Owner do?
Select an answer to reveal the explanation.
Short Explanation
Shipping a half-ready clinic check-in just to make the stopwatch look good is like handing out vaccines from a warm fridge—faster, and that is the problem. Time-to-Market only counts when the Increment is actually Done. A fake speed trophy is still a quality miss.
Full Explanation
Evidence-Based Management’s Time-to-Market Key Value Area measures how quickly the organization can deliver value, not how quickly it can push unfinished work onto residents. An Increment that fails the Definition of Done is not releasable value, and skipping dose-lot verification on a public-health product actively harms Current Value. Gaming T2M by weakening Done teaches the organization the wrong lesson about speed. The Product Owner should reject the false win, keep undone work out of production, and inspect Time-to-Market only on Done Increments.